Showing results (71-80 of 97) with videos related to
Sort By:
Pageof 10
Biological Psychiatry|November 4, 2004
Structural neural networks subserving oculomotor function in first-episode schizophreniaManjinder S Bagary, Samuel B Hutton, Mark R Symms, et al.Journal of Psychopharmacology (Oxford, England)|December 17, 2009
Evaluation of akathisia in patients with schizophrenia, schizoaffective disorder, or bipolar I disorder: a post hoc analysis of pooled data from short- and long-term aripiprazole trialsJohn M Kane, Thomas R E Barnes, Christoph U Correll, et al.Schizophrenia Bulletin|March 21, 2023
Clozapine Optimization: A Delphi Consensus Guideline From the Treatment Response and Resistance in Psychosis Working GroupElias Wagner, Dan Siskind, Peter Falkai, et al.Trials|April 18, 2015
The benefit of minocycline on negative symptoms in early-phase psychosis in addition to standard care - extent and mechanism (BeneMin): study protocol for a randomised controlled trialDanuta M Lisiecka, John Suckling, Thomas R E Barnes, et al.Schizophrenia Bulletin|April 30, 2014
Schizophrenia--time to commit to policy changeW Wolfgang Fleischhacker, Celso Arango, Paul Arteel, et al.Biological Psychiatry|May 11, 2010
Changes in the frontotemporal cortex and cognitive correlates in first-episode psychosisLeticia Gutiérrez-Galve, Claudia A M Wheeler-Kingshott, Daniel R Altmann, et al.Therapeutic Advances in Psychopharmacology|July 7, 2018
Amisulpride augmentation of clozapine for treatment-refractory schizophrenia: a double-blind, placebo-controlled trialThomas R E Barnes, Verity Leeson, Carol Paton, et al.BMJ Open|November 30, 2019
Randomised controlled trial of gradual antipsychotic reduction and discontinuation in people with schizophrenia and related disorders: the RADAR trial (Research into Antipsychotic Discontinuation and Reduction)Joanna Moncrieff, Glyn Lewis, Nick Freemantle, et al.Psychological Medicine|February 18, 2022
Cognitive function in early-phase schizophrenia-spectrum disorder: IQ subtypes, brain volume and immune markersAndrew J Watson, Annalisa Giordano, John Suckling, et al.BMC Psychiatry|August 7, 2016
Design and protocol for the Focusing on Clozapine Unresponsive Symptoms (FOCUS) trial: a randomised controlled trialMelissa Pyle, John Norrie, Matthias Schwannauer, et al.Pageof 10